Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
This analysis describes the epidemiology and outcomes of invasive candidiasis caused by non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy Alliance (PATH Alliance) registry from 2004 to 2008. A total of 2,496 patients with non-albicans species of Candida isolates were identified. The identified species were C. glabrata (46.4%), C. parapsilosis (24.7%), C. tropicalis (13.9%), C. krusei (5.5%), C. lusitaniae (1.6%), C. dubliniensis (1.5%) and C. guilliermondii (0.4%); 111 infections involved two or more species of Candida (4.4%). Non-albicans species accounted for more than 50% of all cases of invasive candidiasis in 15 of the 24 sites (62.5%) that contributed more than one case to the survey. Among solid organ transplant recipients, patients with non-transplant surgery, and patients with solid tumors, the most prevalent non-albicans species was C. glabrata at 63.7%, 48.0%, and 53.8%, respectively. In 1,883 patients receiving antifungal therapy on day 3, fluconazole (30.5%) and echinocandins (47.5%) were the most frequently administered monotherapies. Among the 15 reported species, 90-day survival was highest for patients infected with either C. parapsilosis (70.7%) or C. lusitaniae (74.5%) and lowest for patients infected with an unknown species (46.7%) or two or more species (53.2%). In conclusion, this study expands the current knowledge of the epidemiology and outcomes of invasive candidiasis caused by non-albicans species of Candida in North America. The variability in species distribution in these centers underscores the importance of local epidemiology in guiding the selection of antifungal therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“although C. glabrata has been reported to represent more than 30% of the non-albicans Candida in some geographic areas [4, 6–9].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [7]
In the citing paper
“C. glabrata bloodstream infections are commonly found in elderly individuals, diabetic patients and solid organ transplant recipients [6,8,9].”
From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [8]
In the citing paper
“The emergence of resistant strains, including those becoming resistant to multiple drugs, has been increasingly reported in recent years [14,15,16].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“More than 30 species of Candida have been reported to cause IC [3–6].”
BackgroundSelf-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 2×
“parapsilosis, the early removal of central venous catheters remains an important principle in the management of candidemia caused by this species [29].”
BackgroundSelf-citationAscioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 1×
“from blood cultures and other forms of IC (proven or probable) were defined according to the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group criteria [33].”
MethodCornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · cited 4×
“On reviewing the approaches to antifungal therapy reported by the participating centers, several appear to be at odds with current consensus guidelines [28–30] and reported susceptibility profiles in the literature [14,21].”
BackgroundResultInfluentialEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901 · cited 2×
“7%, in keeping with other reports [1].”
BackgroundSelf-citationAndes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793 · cited 2×
“Indeed Andes et al [39] found in a patient-level T a b le 1 .”
BackgroundSelf-citationAlexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · cited 2×
“glabrata with co-resistance to both azoles and echinocandins in some medical centers [12,13,20].”
BackgroundSelf-citationThe changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758 · cited 2×
“glabrata has been reported by other investigators [23–27]; however, a recent systematic review by Falagas et al.”
BackgroundResultPfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718 · cited 1×
“While some of these species have been designated as ‘emerging’ species, the apparent increased detection of these species may simply reflect the more vigorous efforts to identify clinical isolates of Candida to the species level in recent years [6,20,46].”
BackgroundSelf-citationPfaller, M. A., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4419-4431.2004 · Cited by 694 · cited 3×
“4% of all N-CA isolates in this registry, there are several that merit attention either because they have been shown to cause clusters of infection in the hospital setting, because they are frequently misidentified by conventional methods or represent ‘cryptic’ species, or because they exhibit decreased susceptibility…”
BackgroundSelf-citation
Research works printed but not linked: 1
- 31. Horn D, Neofytos D (2007) Contemporary patterns in the use of antifungal agents in the treatment of invasive fungal infections: perspectives from registries and databases. Curr Fungal Infect Rep 1: 72-78.
Cited by
Items 101–200 of 406
Histone Acetylation/Deacetylation in Candida Albicans and their Potential as Antifungal Targets
Su, S., Li, X., Yang, X., Li, Y., Chen, X., Sun, S., & Jia, S. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0343 · Cited by 36
Jiang, C., Li, Z., Zhang, L., Tian, Y., Dong, D., & Peng, Y. (2016) · Microbiological Research · doi:10.1016/j.micres.2016.06.003 · Cited by 41
Candida glabrata’s Genome Plasticity Confers a Unique Pattern of Expressed Cell Wall Proteins
López-Fuentes, E., Gutiérrez-Escobedo, G., Timmermans, B., Van Dijck, P., De Las Peñas, A., & Castaño, I. (2018) · Journal of Fungi · doi:10.3390/jof4020067 · Cited by 35
“In immunocompromised patients, Candida species are the most commonly isolated fungal species from bloodstream infections (candidemia) in the US, of which Candida albicans is the most frequently found species followed by Candida glabrata [2,3].”
BackgroundPhenolic profile, chemical relationship and antifungal activity of Andean Hypericum species
Tocci, N., Weil, T., Perenzoni, D., Narduzzi, L., Madriñán, S., Crockett, S. L., Nürk, N. M., Cavalieri, D., & Mattivi, F. (2017) · Industrial Crops and Products · doi:10.1016/j.indcrop.2017.10.030 · Cited by 35
Asadzadeh, M., Ahmad, S., Al‐Sweih, N., Hagen, F., Meis, J. F. G. M., & Khan, Z. (2019) · Scientific Reports · doi:10.1038/s41598-018-37855-2 · Cited by 38
Santos, R., Costa, C., Mil-Homens, D., Romão, D., de Carvalho, C. C. C. R., Pais, P., Mira, N. P., Fialho, A. M., & Teixeira, M. C. (2017) · Cellular Microbiology · doi:10.1111/cmi.12686 · Cited by 33
“This observation is mostly likely due to the relatively high prevalence of antifungal drug resistance among C. glabrata clinical isolates (Tscherner et al., 2011; Pfaller et al., 2014).”
BackgroundResultO’Leary, R., Einav, S., Léone, M., Madách, K., Martin, C., & Martín‐Loeches, I. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.11.020 · Cited by 37
“4 albicans Candida infections are also an emerging problem (8).”
BackgroundCandida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity
Ahmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W. A., Joseph, L., & Asadzadeh, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240426 · Cited by 37
Reda, N. M., Hassan, R. M., Salem, S. T., & Yousef, R. (2022) · Infection · doi:10.1007/s15010-022-01888-7 · Cited by 40
“6% of invasive infections in Prospective Antifungal Therapy registry (PATH) data [44].”
BackgroundScharmann, U., Kirchhoff, L., Chapot, V., Dziobaka, J., Verhasselt, H. L., Stauf, R., Buer, J., Steinmann, J., & Rath, P. (2020) · Mycoses · doi:10.1111/myc.13119 · Cited by 37
“TA B L E 1 Appearance of Candida on species level on the different included chromogenic media F I G U R E 1 Morphology after 48 h incubation of Candida albicans (A), Candida dubliniensis (B), Candida krusei (C), Candida tropicalis (D) and Candida glabrata (E) on: (1) CandiSelect™ 4, (2) chromID™ Candida Agar, (3) BBL™…”
MethodRasheed, M., Battu, A., & Kaur, R. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1792773 · Cited by 33
Huang, Y., Wang, F., Chen, Y., Huang, Y., Hsieh, M.-H., Hii, I.-M., Lee, Y.-L., Ho, M., Liu, C.-E., Chen, Y., et al. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.11.002 · Cited by 36
Zheng, Y., Xie, T., Wu, L., Liu, X.-Y., Zhu, L. Y., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00441-y · Cited by 34
Thoughts on the evolution of Core Environmental Responses in yeasts
Brown, A. J. P., Larcombe, D. E., & Pradhan, A. (2020) · Fungal Biology · doi:10.1016/j.funbio.2020.01.003 · Cited by 33
“Both species are frequent causes of life-threatening systemic infections in immunocompromised patients (Morgan, 2005; Pfaller et al., 2014).”
BackgroundMüderris, T., Kaya, S., Örmen, B., Gökmen, A. A., Akpınar, C. V., & Gül, S. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101008 · Cited by 37
Epidemiology of Candidemia in Kuwait: A Nationwide, Population-Based Study
Alobaid, K., Ahmad, S., Asadzadeh, M., Mokaddas, E. M., Al‐Sweih, N., Benwan, K. A., Alfouzan, W. A., Al‐Obaid, I., Jeragh, A., Al-Roomi, E., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080673 · Cited by 35
“Although many epidemiologic studies on invasive Candida infections have been performed, only a few nationwide studies have determined the incidence of candidemia [6,14,29].”
BackgroundInfluentialDewan, E., Biswas, D., Kakati, B., Verma, S., Kotwal, A., & Oberoi, A. (2015) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2015.06.006 · Cited by 35
Candida Efflux ATPases and Antiporters in Clinical Drug Resistance
Prasad, R., Rawal, M. K., & Shah, A. H. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_15 · Cited by 30
N-Acetylglucosamine (GlcNAc) Sensing, Utilization, and Functions in Candida albicans
Du, H., Ennis, C. L., Hernday, A. D., Nobile, C. J., & Huang, G. (2020) · Journal of Fungi · doi:10.3390/jof6030129 · Cited by 30
Moye-Rowley, S. (2018) · Current Genetics · doi:10.1007/s00294-018-0870-4 · Cited by 32
“glabrata making constituting 25% of the remaining infections (Pfaller et al. 2014).”
The regulation of iron homeostasis in the fungal human pathogen Candida glabrata
Devaux, F., & Thiébaut, A. (2019) · Microbiology · doi:10.1099/mic.0.000807 · Cited by 35
“Its incidence has been continuously increasing over the last 30 years [3, 4].”
BackgroundFuture therapies targeted towards eliminatingCandidabiofilms and associated infections
Bandara, N., Matsubara, V. H., & Samaranayake, L. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268530 · Cited by 41
Apsemidou, A., Füller, M. A., Idelevich, E. A., Kurzai, O., Tragiannidis, A., & Groll, A. H. (2020) · Journal of Fungi · doi:10.3390/jof6040380 · Cited by 31
“Among the non-albicans Candida species, Candida lusitaniae is an uncommon pathogen that accounts for approximately 1% of isolates in large datasets of adult and pediatric patients with candidemia and other forms of invasive candidiasis [1,3].”
BackgroundPriya, A., Nivetha, S., & Pandian, S. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.780545 · Cited by 30
Karkowska‐Kuleta, J., Zając, D., Braś, G., Bocheńska, O., Rąpała‐Kozik, M., & Kozik, A. (2017) · Acta Biochimica Polonica · doi:10.18388/abp.2017_1609 · Cited by 31
“…if one takes into account the risk associated with the increasing frequency of invasive infections and candidemia caused by this species among neonates, patients with impaired immunity and critically ill individuals (Chatzinikolaou & Raad, 2000; Pfaller et al., 2014; Wadile & Bhate, 2015).”
BackgroundInfluentialFraser, M., Borman, A. M., Thorn, R. M. S., & Lawrance, L. M. (2019) · Medical Mycology · doi:10.1093/mmy/myz053 · Cited by 32
Chew, S. Y., Brown, A. J. P., Lau, B. Y. C., Cheah, Y. K., Ho, K. L., Sandai, D. A., Hassan, Y., & Than, L. T. L. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-020-00700-8 · Cited by 28
Guo, J., Zhang, M., Qiao, D., Shen, H., Wang, L., Wang, D., Li, L., Liu, Y., Lu, H., Wang, C., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.644000 · Cited by 31
Odiba, A. S., Durojaye, O. A., Ezeonu, I. M., Mgbeahuruike, A. C., & Nwanguma, B. C. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s360973 · Cited by 33
“93 Combining the prevalence of the other unidentified NAC species and the NAC (identified) species, we show that NAC has a greater prevalence than C. albicans , and other studies have corroborated this observation, 94,95 making the emergence of NAC species of important concern.”
Jospe‐Kaufman, M., Ben‐Zeev, E., Mottola, A., Dukhovny, A., Berman, J. G., Carmeli, S., & Fridman, M. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202314728 · Cited by 29
Raman, N., Lee, M., Lynn, D. M., & Palecek, S. P. (2015) · Pharmaceuticals · doi:10.3390/ph8030483 · Cited by 32
“tropicalis, have increasingly been observed as infectious agents in hospital settings and therefore there is a growing need to develop drugs or test existing drugs to combat them [33].”
Guo, L., Xiao, M., Cao, B., Qu, F., Zhan, Y., Hu, Y., Wang, X., Liang, G., Gu, H., Qi, J., et al. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0036 · Cited by 30
Sanches, M. D., Mimura, L. A. N., de Oliveira, L. R. C., Ishikawa, L. L. W., Garces, H. G., Bagagli, E., Sartori, A., Kurokawa, C. S., & Fraga‐Silva, T. F. D. C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02968 · Cited by 31
“Non-albicans Candida species are also found in the CNS and the most frequent pathogenic species are Candida glabrata, Candida parapsilosis, Candida tropicalis and Candida krusei (Storti et al., 2012; Pfaller et al., 2014; Turner and Butler, 2014).”
BackgroundTseng, T.-Y., Chen, T., Ho, C., Lin, P., Chou, C.-H., Tsai, C.-T., Wang, J.-H., Chi, C.-Y., & Ho, M. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.08.015 · Cited by 32
“The age and sex distribution of our patients were consistent with the patients of other previous studies.(5,21,22) Similar to prior studies, malignancy, especially gastrointestinal solid tumors, remained the most common underlying disease (50%) in patients with CG-BSI.”
BackgroundResultInfluentialBadiee, P., Boekhout, T., Haddadi, P., Mohammadi, R., Ghadimi-Moghadam, A., Soltani, J., Mahmoudabadi, A. Z., Mousavi, S. A. A., Najafzadeh, M. J., Diba, K., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02453-22 · Cited by 36
Ashkenazi‐Hoffnung, L., & Danziger, C. R. (2023) · Journal of Fungi · doi:10.3390/jof9020176 · Cited by 29
Trabasso, P., Matsuzawa, T., Fagnani, R., Muraosa, Y., Tominaga, K., Resende, M. R., Kamei, K., Mikami, Y., Schreiber, A. Z., & Moretti, M. L. (2014) · Mycopathologia · doi:10.1007/s11046-014-9830-9 · Cited by 34
“Since there is concern over the increasing rates of the CPC infections worldwide [7, 49, 52], our present experiments confirmed the usefulness of LAMP primers for correct identification of each the three species of the complex.”
Figueiredo-Carvalho, M. H. G., Ramos, L. D. S., Barbedo, L. S., Chaves, A. L. D. S., Muramoto, I. A., Santos, A. L. S. D., Almeida-Paes, R., & Zancopé-Oliveira, R. M. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150376 · Cited by 26
“Moreover, it is the most common species of invasive fungal infections among non-albicans Candida species in North America (Lockhart et al. 2012, Pfaller et al. 2014) and Central Europe (De Luca et al. 2012, Milazzo et al. 2014).”
BackgroundMixInYeast: A Multicenter Study on Mixed Yeast Infections
Medina, N., Soto-Debrán, J. C., Seidel, D., Akyar, I., Badali, H., Barac, A. M., Bretagne, S., Çağ, Y., Cassagne, C., Castro, C., et al. (2020) · Journal of Fungi · doi:10.3390/jof7010013 · Cited by 29
Impact of Obesity in Patients with Candida Bloodstream Infections: A Retrospective Cohort Study
Barber, K. E., Wagner, J. L., Miller, J. M., Lewis, E., & Stover, K. R. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00285-7 · Cited by 27
Zhang, L., Yu, S.-Y., Chen, S. C.-A., Xiao, M., Kong, F., Wang, H., Ning, Y., Lu, M., Sun, T., Hou, X., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01320 · Cited by 26
“parapsilosis infection is increasing among hospitalized patients and has become one of the main pathogens causing candidemia in certain geographical areas including China (Guinea, 2014; Pfaller et al., 2014; Puig-Asensio et al., 2014; Strollo et al., 2016).”
BackgroundSá, L. G. D. A. V., da Silva, C. R., Neto, J. B. D. A., do Nascimento, F. B. S. A., Barroso, F. D. D., da Silva, L. J., Cabral, V. P. D. F., Barbosa, A. D., Silva, J., Marinho, E. S., et al. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001241 · Cited by 25
McCort, M., & Tsai, H. (2023) · Mycopathologia · doi:10.1007/s11046-023-00754-w · Cited by 26
“Bloodstream infections from Candida krusei , which are more common in patients with hematologic malignancy due to prior azole exposure [10, 13], had the highest mortality rate (52.9”
BackgroundInfluentialThe distribution and drug susceptibilities of clinical Candida species in TSARY 2014
Zhou, Z.-L., Lin, C.-C., Chu, W.-L., Yang, Y.-L., & Lo, H. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.09.009 · Cited by 24
Kodedová, M., & Sychrová, H. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.06.005 · Cited by 27
Kumar, A., Nair, R., Kumar, M., Banerjee, A., Chakrabarti, A., Rudramurthy, S. M., Bagga, R., Gaur, N. A., Mondal, A. K., & Prasad, R. (2020) · Folia Microbiologica · doi:10.1007/s12223-020-00785-6 · Cited by 24
The involvement of the Candida glabrata trehalase enzymes in stress resistance and gut colonization
Ende, M. V., Timmermans, B., Vanreppelen, G., Siscar-Lewin, S., Fischer, D., Wijnants, S., Romero, C. L., Yazdani, S., Rogiers, O., Demuyser, L., et al. (2021) · Virulence · doi:10.1080/21505594.2020.1868825 · Cited by 23
Vargas-Espíndola, L. A., Cuervo, S. I., Enciso-Olivera, J. L., Gómez-Rincón, J. C., Cetina, L. P. J., Sánchez, R., García-Guzmán, K., López-Mora, M. J., Álvarez, C., Cortés, J. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9040400 · Cited by 26
“Finally, no association was found between mortality and gender or species, as described in the literature [11,24,34].”
BackgroundMisas, E., Seagle, E. E., Jenkins, E. N., Rajeev, M., Hurst, S. F., Nunnally, N. S., Bentz, M. L., Lyman, M., Berkow, E. L., Harrison, L. H., et al. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-23 · Cited by 26
Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification
Rizzato, C., Lombardi, L., Zoppo, M., Lupetti, A., & Tavanti, A. (2015) · Journal of Fungi · doi:10.3390/jof1030367 · Cited by 25
“Among the most significant emerging pathogens are yeast such as Candida glabrata [3,4], Trichosporon spp.”
BackgroundCataldi, V., Campli, E. D., Fazii, P., Traini, T., Cellini, L., & Giulio, M. D. (2016) · Medical Mycology · doi:10.1093/mmy/myw126 · Cited by 26
Larcombe, D. E., Bohovych, I., Pradhan, A., Ma, Q., Hickey, E., Leaves, I., Cameron, G. A., Avelar, G. M., de Assis, L. J., Childers, D. S., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011505 · Cited by 22
Li, S., Wu, H.-T., Liu, Y., Jiang, Y.-Y., Zhang, Y., Liu, W., Zhu, K., Li, D., & Zhang, H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01025 · Cited by 24
“Candida albicans is the most common cause of disseminated candidiasis (Pfaller et al., 2014).”
BackgroundAhangarkani, F., Badali, H., Rezai, M. S., Shokohi, T., Abtahian, Z., Nesheli, H. M., Karami, H., Roilides, E., & Tamaddoni, A. (2019) · Current Medical Mycology · doi:10.18502/cmm.5.1.535 · Cited by 24
“2004-2008 USA - Cancer - Stem cell transplantation - Chemotherapy Both 9/2496 0 0 NS [22]”
BackgroundTranscriptional regulation of the caspofungin-induced cell wall damage response in Candida albicans
Heredia, M. Y., Gunasekaran, D., Ikeh, M. A. C., Nobile, C. J., & Rauceo, J. M. (2020) · Current Genetics · doi:10.1007/s00294-020-01105-8 · Cited by 23
Participation of the ABC Transporter CDR1 in Azole Resistance of Candida lusitaniae
Borgeat, V., Brandalise, D., Grenouillet, F., & Sanglard, D. (2021) · Journal of Fungi · doi:10.3390/jof7090760 · Cited by 24
“Candida albicans is considered to be the most common species isolated from blood cultures, however, fungal infections caused by non-albicans Candida species are on the rise [2].”
BackgroundRuma, Y. N., Keniya, M. V., Tyndall, J. D. A., & Monk, B. C. (2022) · Journal of Fungi · doi:10.3390/jof8010069 · Cited by 22
“can result in major disease outbreaks in elderly care facilities [8–11] that can be lethal for vulnerable individuals [1,3,4,12].”
BackgroundSharifi, M., Badiee, P., Abastabar, M., Morovati, H., Haghani, I., Noorbakhsh, M., & Mohammadi, R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1152552 · Cited by 23
Metallacarborane Derivatives as Innovative Anti-Candida albicans Agents
Kubiński, K., Masłyk, M., Janeczko, M., Goldeman, W., Nasulewicz‐Goldeman, A., Psurski, M., Martyna, A., Boguszewska‐Czubara, A., Cebula, J., & Goszczyński, T. M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01167 · Cited by 20
Neves, A., Cartágenes-Pinto, A. C., Rocha, D. A. S., de Sá, L. F. R., Junqueira, M. D. L., & Ferreira‐Pereira, A. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140717 · Cited by 27
Clinical utility of antifungal susceptibility testing
McCarty, T. P., Luethy, P. M., Baddley, J. W., & Pappas, P. G. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac067 · Cited by 19
A Risk Score for Fluconazole Failure among Patients with Candidemia
Ostrosky-Zeichner, L. L., Harrington, R. L., Azie, N. E., Yang, H., Li, N., Zhao, J., Koo, V., & Wu, E. Q. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02091-16 · Cited by 20
“An analysis of 313 57 isolates of Candida glabrata over a 10-year period demonstrated an increase in resistance to 58 fluconazole from 18% to 30% (15, 16).”
MethodSelf-citationAlmoosa, Z., Ahmed, G. Y., Omran, A., AlSarheed, A. S., Alturki, A., Alaqeel, A., Alshehri, M., AlFawaz, T. S., & AlShahrani, D. A. (2017) · Saudi Medical Journal · doi:10.15537/smj.2017.11.21116 · Cited by 20
Archambault, L. S., Trzilova, D., Gonia, S., Gale, C. A., & Wheeler, R. T. (2019) · mBio · doi:10.1128/mbio.00266-19 · Cited by 21
Xiao, G., Liao, W., Zhang, Y., Luo, X., Zhang, C., Li, G., Yang, Y., & Xu, Y. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05291-1 · Cited by 22
Integrative functional analysis uncovers metabolic differences between Candida species
Begum, N., Lee, S., Portlock, T., Pellón, A., Nasab, S. D. S., Nielsen, J., Uhlén, M., Moyes, D. L., & Shoaie, S. (2022) · Communications Biology · doi:10.1038/s42003-022-03955-z · Cited by 21
Biofilm Formation as a Pathogenicity Factor of Medically Important Fungi
Vila, T. V. M., & Rozental, S. (2016) · InTech eBooks · doi:10.5772/62768 · Cited by 30
Torosantucci, A., Tumbarello, M., Bromuro, C., Chiani, P., Posteraro, B., Sanguinetti, M., Cauda, R., & Cassone, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-02977-6 · Cited by 20
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade
Ferngren, G., Yu, D. C., Ünalan-Altıntop, T., Dinnétz, P., & Özenci, V. (2024) · Mycoses · doi:10.1111/myc.13729 · Cited by 19
Rahn, S., Schuck, A., Kondakci, M., Haas, R. R., Neuhausen, N., Pfeffer, K., & Henrich, B. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.10.003 · Cited by 18
MF, N., F, I., S, J., LA, W., NA, G., & T, L. (2017) · Journal of Microbiology and Modern Techniques · doi:10.15744/2575-5498.2.101 · Cited by 16
“The emergence is partly attributable to prophylactic treatment strategies, and poses a challenge for effective therapy due to inherent resistance to a number of antifungal agents [1,6-21].”
BackgroundOtto, C. C., & Babady, N. E. (2023) · Mycopathologia · doi:10.1007/s11046-023-00765-7 · Cited by 21
“Data from the Prospective Antifungal Therapy (PATH) Registry [16] reported C. glabrata as the predominant cause of non-albicans candidemia in patients with solid tumors similar to data reported in the current study.”
ResultA New Determinant of Candida glabrata Virulence: The Acetate Exporter CgDtr1
Romão, D., Cavalheiro, M., Mil‐Homens, D., Santos, R., Pais, P., Costa, C., Takahashi‐Nakaguchi, A., Fialho, A. M., Chibana, H., & Teixeira, M. C. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00473 · Cited by 18
“Infections caused by this pathogenic yeast have increased worldwide (Rodrigues et al., 2014; Yapar, 2014), which is likely due to the relatively high prevalence of antifungal drug resistance among C. glabrata clinical isolates (Tscherner et al., 2011; Pfaller et al., 2014).”
BackgroundMohamed, N. A., Pathmanathan, S. G., Hussin, H., & Zaini, A. B. (2018) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.9634 · Cited by 20
“Although Candida albicans remains the major cause of invasive candidiasis, increasing trends in infections caused by non-albicans species have been observed in recent years worldwide [4-6] including Malaysia [7-9].”
BackgroundTome, M., Zupan, J., Tomičić, Z., Matos, T., & Raspor, P. (2018) · PeerJ · doi:10.7717/peerj.4999 · Cited by 21
“Candida albicans is the dominant pathogen, but the incidence of invasive infections caused by Candida glabrata has been steadily rising (Pfaller et al., 2012b; Pfaller et al., 2014).”
BackgroundChen, X., Shen, M., Feng, Q., Yang, G., Tian, R., Yao, S., & Zha, H. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11021-2 · Cited by 17
“Identification of Candida isolates at the species level is important for empiric treatment of early suspected candidemia infections [49].”
Gaspar‐Cordeiro, A., Amaral, C., Pobre, V., Antunes, W., Petronilho, A., Paixão, P., Matos, A., & Pimentel, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.920574 · Cited by 18
Development of biopolymer films loaded with fluconazole and thymol for resistant vaginal candidiasis
Conte, J., Saatkamp, R. H., Sanches, M. P., Argenta, D. F., Machado, G. D. R. M., Kretzer, I. F., Parize, A. L., & Caon, T. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133356 · Cited by 17
Mandelblat, M., Frenkel, M., Abbey, D., Ben‐Ami, R., Berman, J. G., & Segal, E. (2017) · Mycoses · doi:10.1111/myc.12623 · Cited by 22
Dispersal of single and mixed non- albicans Candida species biofilms by β-1,3-glucanase in vitro
Tan, Y., Leonhard, M., Ma, S., Moser, D., & Schneider‐Stickler, B. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.10.057 · Cited by 18
Machado, G. D. R. M., Pippi, B., Lana, D. F. D., Amaral, A. P. S., Teixeira, M. L., de Souza, K. C. B., & Fuentefría, A. M. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2016.1158286 · Cited by 21
“In their study, Pfaller et al. (2014) found that the emergence of candidemias caused by non-albicans species exceeds C. albicans in most tertiary care medical centres in North America.”
BackgroundInfluentialWu, Y.-M., Huang, P., Lu, J., Shie, S., Ye, J.-J., Wu, T., & Huang, C. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.10.002 · Cited by 17
Antifungal susceptibility of yeast bloodstream isolates collected during a 10‐year period in Austria
Beyer, R., Spettel, K., Zeller, I., Lass‐Flörl, C., Achleitner, D., Krause, R., Apfalter, P., Buzina, W., Strauss, J., Gregori, C., et al. (2019) · Mycoses · doi:10.1111/myc.12892 · Cited by 17
Pérez-García, L. A., Macías-Pérez, J. R., León‐Buitimea, A., Alvarado‐Sánchez, B., Ramírez-Quijas, M. D., Navarro-Arias, M. J., & Rodríguez-Reyes, S. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3_3 · Cited by 19
Use of echinocandin prophylaxis in solid organ transplantation
Giannella, M., Husain, S., Saliba, F., & Viale, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx449 · Cited by 17
Molecular simulations of fluconazole-mediated inhibition of sterol biosynthesis
Siqueira, T. H., & Martínez, L. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1614998 · Cited by 19
“This is a major problem as fluconazole is the most commonly used antifungal agent for prophylaxis and treatment of Candida infections in many parts of the world (Bongomin et al., 2017; Castanheira, Messer, Jones, Farrell, & Pfaller, 2014; Pfaller et al., 2014).”
BackgroundLactobacillus rhamnosus strains of oral and vaginal origin show strong antifungal activity in vitro
Jørgensen, M. R., Rikvold, P. D., Lichtenberg, M., Jensen, P. Ø., Kragelund, C., & Twetman, S. (2020) · Journal of Oral Microbiology · doi:10.1080/20002297.2020.1832832 · Cited by 16
Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients
Corredores, J., Jaouni, T., Habot‐Wilner, Z., Kramer, M., Shulman, S., Jabaly-Habib, H., AlTalbishi, A., Halpert, M., Averbukh, E., Levy, J., et al. (2021) · International Journal of Ophthalmology · doi:10.18240/ijo.2021.01.14 · Cited by 16
Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents
Skłodowski, K., Chmielewska, S. J., Depciuch, J., Deptuła, P., Piktel, E., Daniluk, T., Zakrzewska, M., Czarnowski, M., Cieśluk, M., Durnaś, B., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111940 · Cited by 16
“There is a growing number of drug-resistant fungi, including multi-drug resistant (MDR) strains on four continents, namely: Asia (Pakistan, India, and Japan), Africa (South Africa), South America (Venezuela) [16], and North America (USA/Canada) [17].”
BackgroundPfaller, M. A. (2015) · Journal of Fungi · doi:10.3390/jof1020217 · Cited by 19
“lusitaniae, and other less common species [3,6,9,32,86,87].”
Self-citationSiqueira, R. A., Doi, A. M., Crossara, P. P. D. P., Koga, P. C. M., Marques, A. G., Nunes, F. G., Pasternak, J., & Martino, M. D. V. (2018) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2017.11.001 · Cited by 17
Sethiya, P., Rai, M. N., Rai, R., Parsania, C., Tan, K., & Wong, K. H. (2019) · Fungal Biology · doi:10.1016/j.funbio.2019.12.005 · Cited by 16
Sá, L. G. D. A. V., da Silva, C. R., de Rosana, S. C., Neto, J. B., Sampaio, L. S., do Nascimento, F. B. S. A., Barroso, F. D. D., da Silva, L. J., Queiroz, H. A., Cândido, T. M., et al. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0075 · Cited by 17
SUMOylation in Human Pathogenic Fungi: Role in Physiology and Virulence
Sahu, M. S., Patra, S., Kumar, K., & Kaur, R. (2020) · Journal of Fungi · doi:10.3390/jof6010032 · Cited by 17
Taj‐Aldeen, S. J., Salah, H., Perez, W. B., Almaslamani, M., Motyl, M. R., AbdulWahab, A., Healey, K. R., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00214-18 · Cited by 17
Antifungal and anti-biofilm activity of designed derivatives from kyotorphin
de Andrade, V. M., Bardají, E., Heras, M., Ramu, V. G., Junqueira, J. C., dos Santos, J. D., Castanho, M. A. R. B., & Conceição, K. (2019) · Fungal Biology · doi:10.1016/j.funbio.2019.12.002 · Cited by 16
Ayadi, R., Sitterlé, E., d’Enfert, C., Dannaoui, É., & Bougnoux, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01286 · Cited by 16
Superenhanced Removal of Fungal Biofilms by Protease‐Functionalized Amphotericin B Nanocarriers
Weldrick, P. J., Hardman, M. J., & Paunov, V. N. (2020) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000027 · Cited by 16
Materials used to prevent adhesion, growth, and biofilm formation ofCandidaspecies
Tornero-Gutiérrez, F., Ortiz-Ramírez, J. A., López-Romero, E., & Cuéllar‐Cruz, M. (2023) · Medical Mycology · doi:10.1093/mmy/myad065 · Cited by 15
Zilli, D. M. W., Lopes, R. G., Júnior, S. L. A., Barros, L. M., Miletti, L. C., & Stambuk, B. U. (2015) · Microbiological Research · doi:10.1016/j.micres.2015.06.008 · Cited by 16
Metadata
- Authors
- Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E.
- Affiliations
- University of Iowa (US)
- University of Wisconsin–Madison (US)
- Cooper Medical School of Rowan University (US)
- University of Toronto (CA)
- Astellas Pharma (United States) (US)
- Corresponding author
- Pfaller, Michael A.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-07-03
- Volume
- 9
- Issue
- 7
- Pages
- e101510
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4081561
- OpenAlex
- W2053909542
- Cited by
- 396
- References
- 69
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 21 · 2023: 33 · 2022: 34 · 2021: 33 · 2020: 47 · 2019: 48 · 2018: 41 · 2017: 43 · 2016: 39 · 2015: 34 · 2014: 4
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Pfizer
- Massachusetts General Hospital
- University of Nebraska Medical Center
- University of Miami
- University of Pennsylvania
- Emory University
- Bunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago
- University of Minnesota
- University of Washington
- Johns Hopkins University
- University of Pittsburgh
- Hamilton Health Sciences
- Thomas Jefferson University
- University of Arkansas for Medical Sciences
- City of Hope
- Astellas Pharma
- University of Texas MD Anderson Cancer Center
- Medical Center, University of Pittsburgh
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- invasive candidiasis, non-albicans Candida, Candida glabrata, Candida parapsilosis, Candida tropicalis, Candida krusei, Candida lusitaniae, Candida dubliniensis, Candida guilliermondii, Candida species distribution, antifungal therapy, fluconazole, echinocandins, 90-day survival, solid organ transplant recipients, solid tumors
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antifungal Agents, Candida, Child, Child, Preschool, Drug Therapy, Combination, Female, Humans, Infant, Male, Middle Aged, Prospective Studies, Registries, Fluconazole, Prevalence, Survival Rate, Treatment Outcome, Echinocandins, Young Adult, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
